The purpose of the Facilities and Logistics Services (FLS) is to provide a safe, reliable functioning building? and associated systems in support of the scientific focus of the Galveston National Laboratory. In pursuit of? these aims, the FLS will provide a computer-aided preventive maintenance program designed to minimize? unscheduled downtime of equipment and systems. The Facility Operations Manager, and/or, his/her? Assistant Manager will provide coordination and oversight to the daily maintenance activities. A proactive? maintenance effort will be deployed wherever possible; however, there will be some measure of unplanned? work on occasion. Therefore, a user-friendly work request system will be provided to obtain services as? needed. The Director of the FLS Core will also oversee the day-to-day operations of required logistics? services as they relate to domestic material delivery and distribution, as well as the daily cleaning services.? The priorities of the core are the following:? 1. Ensure reliability of systems and controls as it relates to staff safety? 2. meet regulatory requirements? 3. Coordinate processes and review incidents? 4. Provide reliable and functional operations of the physical environment as it relates to staff and? programmatic support? 5. Effectively manage energy needs? 6. Provide oversight and coordinate space utilization? 7. Schedule moves and equipment installation

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
National Biocontainment Laboratory Operation Cooperative Agreement (UC7)
Project #
1UC7AI070083-01
Application #
7262340
Study Section
Special Emphasis Panel (ZAI1-RCG-M (M1))
Project Start
2006-05-03
Project End
2011-04-30
Budget Start
2006-05-03
Budget End
2007-04-30
Support Year
1
Fiscal Year
2006
Total Cost
$146,173
Indirect Cost
Name
University of Texas Medical Br Galveston
Department
Type
DUNS #
800771149
City
Galveston
State
TX
Country
United States
Zip Code
77555
Andersson, Jourdan A; Sha, Jian; Kirtley, Michelle L et al. (2018) Combating Multidrug-Resistant Pathogens with Host-Directed Nonantibiotic Therapeutics. Antimicrob Agents Chemother 62:
Beasley, David W C; Brasel, Trevor L; Comer, Jason E (2016) First vaccine approval under the FDA Animal Rule. NPJ Vaccines 1:16013
Sha, Jian; Kirtley, Michelle L; Klages, Curtis et al. (2016) A Replication-Defective Human Type 5 Adenovirus-Based Trivalent Vaccine Confers Complete Protection against Plague in Mice and Nonhuman Primates. Clin Vaccine Immunol 23:586-600
Fitts, Eric C; Andersson, Jourdan A; Kirtley, Michelle L et al. (2016) New Insights into Autoinducer-2 Signaling as a Virulence Regulator in a Mouse Model of Pneumonic Plague. mSphere 1:
Tiner, Bethany L; Sha, Jian; Cong, Yingzi et al. (2016) Immunisation of two rodent species with new live-attenuated mutants of Yersinia pestis CO92 induces protective long-term humoral- and cell-mediated immunity against pneumonic plague. NPJ Vaccines 1:16020
Andersson, Jourdan A; Fitts, Eric C; Kirtley, Michelle L et al. (2016) New Role for FDA-Approved Drugs in Combating Antibiotic-Resistant Bacteria. Antimicrob Agents Chemother 60:3717-29
Ponnusamy, Duraisamy; Fitts, Eric C; Sha, Jian et al. (2015) High-throughput, signature-tagged mutagenic approach to identify novel virulence factors of Yersinia pestis CO92 in a mouse model of infection. Infect Immun 83:2065-81
Tiner, Bethany L; Sha, Jian; Kirtley, Michelle L et al. (2015) Combinational deletion of three membrane protein-encoding genes highly attenuates yersinia pestis while retaining immunogenicity in a mouse model of pneumonic plague. Infect Immun 83:1318-38
Rasmussen, Lynn; Tigabu, Bersabeh; White, E Lucile et al. (2015) Adapting high-throughput screening methods and assays for biocontainment laboratories. Assay Drug Dev Technol 13:44-54
Boisen, Matthew L; Schieffelin, John S; Goba, Augustine et al. (2015) Multiple circulating infections can mimic the early stages of viral hemorrhagic fevers and possible human exposure to filoviruses in Sierra Leone prior to the 2014 outbreak. Viral Immunol 28:19-31

Showing the most recent 10 out of 43 publications